Monthly Archives: March 2019
Covering the Cover
A single-center, randomized trial showed that the combination of fecal microbiota transplantation and vancomycin resulted in more clinical resolution compared with either fidaxomicin or vancomycin alone. Continue reading
Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?
Simon TG, Ma Y, Ludvigsson JF, et al. Association between aspirin use and risk of hepatocellular carcinoma. JAMA Oncol 2018;4:1683–1690. Continue reading
Acute-on-Chronic Liver Failure in Cirrhosis Requires Expedited Decision for Liver Transplantation
Acute-on-chronic liver failure (ACLF) is an extremely relevant clinical entity, recently characterized by the Canonic Study (2013),1,2 consisting of the simultaneous development of acute decompensation (ascites, encephalopathy, and/or gastrointestinal … Continue reading
Vanderbilt University Press holding sale during March; all books 40 percent off
Vanderbilt athletes raise money for Children’s Hospital with Dance Marathon
Discovery Sciences Emerging Scholars Lectures features Luis Natividad this afternoon
Advanced Imaging in Mass Spectrometry Laboratory Course to be April 9-12
VUMC in the news
A roundup of a few recent stories from the press about Vanderbilt University Medical Center. Continue reading
“Momentum”: Therapy advancement for an aggressive lung cancer
Patients with stage IV small cell lung cancer lived longer when given the immunotherapy atezolizumab with chemotherapy, setting the stage for what could become the first new treatment approved in decades for this particularly aggressive form of lung ca… Continue reading
Defining Personalized Care stories: Jordyn Spann
At age 32, Jordyn Spann — a wife and mother of four — learned she had a brain tumor. Her mission to find the best surgeons led her to Vanderbilt and a 16-hour surgery that removed her acoustic neuroma and returned her to family life. Continue reading